Role of Melatonin in Health and Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 19087
Special Issue Editor
Interests: aging and oxidative stress
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Synthesized melatonin, with circadian rhythmicity by the pineal gland, and by other tissues in humans, is fundamentally known as a regulator of the wake-sleep cycle, and for its antioxidant capacity, by purifying free radicals generated in oxidative stress reactions. Environmental darkness stimulates its synthesis, while the presence of light and other factors, such as age, decrease it. In regards to the mechanism of action of this indolamine, at least three types of membrane receptors and nuclear receptors of the RZR/ROR type have also been identified.
In addition to jet lag, due to its physiological decrease with age, melatonin is used to prevent processes derived from aging. It is an essential molecule in the treatment of diseases related to chronodisruption, such as accelerated aging; sleep and mood disorders; cognitive impairment, due to its neuroprotective capacity; metabolic syndrome; cardiovascular diseases; some types of cancer. Due to its function, not only antioxidant, but also anti-inflammatory and immunomodulatory, its therapeutic indications are expanding at the level of transplant medicine. Recently, the use of melatonin in infections such as that caused by COVID-19 has been proposed.
As a result of its broad physiological actions and its potential beneficial effects, together with its high bioavailability and little or no toxicity, melatonin has been proposed as a safe and effective treatment for numerous diseases.
Dr. Laura Lõpez-Pingarrõn
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melatonin
- pineal gland
- sleep-wake cycle
- chronodisruption
- oxidative stress
- aging
- neuroprotector
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.